Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 6/20 | 0.63 |
| ▸ | ACAT1 | P24752 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.36 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.36 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29972770 | 1.00 | SOAT1 (0.63) | SOAT1ACAT1KDM4ESMN1; SMN2HPGD | |
| SCHEMBL9565792 | 1.00 | SOAT1 (0.63) | SOAT1ACAT1KDM4ESMN1; SMN2HPGD | |
| SCHEMBL9597124 | 0.87 | SOAT1 (0.48) | SOAT1ACAT1 | |
| SCHEMBL9525341 | 0.86 | SOAT1 (0.47) | SOAT1ACAT1 | |
| SCHEMBL9201449 | 0.77 | SOAT1 (1.00) | SOAT1ACAT1 | |
| SCHEMBL3379092 | 0.77 | SOAT1 (1.00) | SOAT1ACAT1 | |
| Hydrochloric Acid SCHEMBL9212683 | 0.76 | SOAT1 (0.98) | SOAT1ACAT1 | |
| SCHEMBL9213110 | 0.76 | SOAT1 (0.98) | SOAT1ACAT1 | |
| SCHEMBL9202439 | 0.76 | SOAT1 (0.63) | SOAT1ACAT1KDM4ESMN1; SMN2HPGD | |
| SCHEMBL7640471 | 0.75 | KDM4E (0.36) | SOAT1ACAT1KDM4ESMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2003513909-A | — | — | 2003-04-15 | — | — | JP | claimed |
| EP-1229907-A1 | PREVENTION OF PLAQUE RUPTURE BY ACAT INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2002-08-14 | — | — | EP | claimed |
| WO-2001034127-A1 | PREVENTION OF PLAQUE RUPTURE BY ACAT INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-05-17 | — | — | WO | claimed |
| EP-1098662-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2001-05-16 | — | — | EP | claimed |
| WO-2000004892-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2000-02-03 | — | — | WO | claimed |
| EP-0773940-A1 | PROCESS FOR SYNTHESIS OF SUBSTITUTED SULPHOXIDES | Astra Aktiebolag (SE) | 1997-05-21 | — | — | EP | claimed |
| WO-1996002535-A1 | PROCESS FOR SYNTHESIS OF SUBSTITUTED SULPHOXIDES | ASTRA AKTIEBOLAG (SE) | 1996-02-01 | — | — | WO | claimed |
| WO-1993001183-A1 | IMIDAZOLE DERIVATIVE AS ACAT INHIBITOR | RHONE-POULENC RORER LIMITED (GB) | 1993-01-21 | — | — | WO | claimed |
| EP-0523941-A1 | Imidazoles as ACAT inhibitor | RHONE-POULENC RORER LIMITED (GB) | 1993-01-20 | — | — | EP | claimed |
| EP-0773940-B2 | PROCESS FOR SYNTHESIS OF SUBSTITUTED SULPHOXIDES | ASTRAZENECA AB (SE) | 2010-11-17 | — | — | EP | disclosed |
| EP-0773940-B1 | PROCESS FOR SYNTHESIS OF SUBSTITUTED SULPHOXIDES | ASTRAZENECA AB (SE) | 2003-06-04 | — | — | EP | disclosed |
| EP-1098662-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2001-05-16 | — | — | EP | disclosed |
| WO-2000004892-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2000-02-03 | — | — | WO | disclosed |
| US-5948789-A | ASYMMETRIC OXIDATION OF A PRO-CHIRAL SULPHIDE TO THE SINGLE ENANTIOMERS OR AN ENANTIOMERICALLY ENRICHED FORM OF THE CORRESPONDING SULPHOXIDE. OPTICALLY PURE SUBSTITUTED 2-(2-PYRIDINYLMETHYL-SULPHINYL)-1H-BENZIMIDAZOLES. | ASTRA AKTIEBOLAG (SE) | 1999-09-07 | — | — | US | disclosed |
| WO-1993001183-A1 | IMIDAZOLE DERIVATIVE AS ACAT INHIBITOR | RHONE-POULENC RORER LIMITED (GB) | 1993-01-21 | — | — | WO | disclosed |
| WO-1993001183-A1 | IMIDAZOLE DERIVATIVE AS ACAT INHIBITOR | RHONE-POULENC RORER LIMITED (GB) | 1993-01-21 | — | — | WO | disclosed |
| EP-0523941-A1 | Imidazoles as ACAT inhibitor | RHONE-POULENC RORER LIMITED (GB) | 1993-01-20 | — | — | EP | disclosed |
| EP-0523941-A1 | Imidazoles as ACAT inhibitor | RHONE-POULENC RORER LIMITED (GB) | 1993-01-20 | — | — | EP | disclosed |
| EP-0510036-A1 | 2-SUBSTITUTED 4,5-DIPHENYL-IMIDAZOLES. | RHONE POULENC RORER SA (FR) | 1992-10-28 | — | — | EP | disclosed |
| WO-1991010662-A1 | 2-SUBSTITUTED 4,5-DIPHENYL-IMIDAZOLES | RHONE-POULENC RORER S.A. (FR) | 1991-07-25 | — | — | WO | disclosed |